AI and Neurological Rare & Neuroimmune Diseases ── 2026-11-14
New papers on neurological rare and neuroimmune diseases and AI, collected from journal feeds, PubMed (searched across all journals) and OpenAlex (a public index used instead of Google Scholar), judged by Jev (an AI that makes language judgements): original research, AI central, which of 9 disease groups, treatment or trials, and then ranked by importance up to a daily limit. Journals are not filtered by impact factor; each paper shows its journal's IF-equivalent (OpenAlex two-year mean citedness) and the date of that value. Each entry shows the full original abstract.
Read by disease: Basic research(0) · ALS(0) · Parkinson's(0) · Hereditary neurodegeneration(0) · Neuromuscular(0) · Multiple sclerosis(1) · NMOSD/MOGAD(0) · Myasthenia gravis(0) · Autoimmune encephalitis/CIDP/GBS(0)
Neurodegeneration and neuroimmunology research and AI
No new qualifying paper for this issue.
ALS: treatment, trials and AI
No new qualifying paper for this issue.
Parkinson's disease and parkinsonism: treatment, trials and AI
No new qualifying paper for this issue.
Hereditary neurodegenerative diseases: treatment, trials and AI
No new qualifying paper for this issue.
Neuromuscular diseases (muscular dystrophy, SMA): treatment, trials and AI
No new qualifying paper for this issue.
Multiple sclerosis: treatment, trials and AI
- Abstract
BACKGROUND: Neurological diseases can lead to significant cognitive impairment. Linking magnetic resonance imaging (MRI)-derived measures of brain structure with clinical assessments of cognitive function remains challenging, as conventional statistical methods and traditional machine learning approaches may struggle to capture complex relationships between brain structure and cognitive outcomes, hindering the development of reliable imaging biomarkers. Although deep learning methods offer greater predictive capabilities, their black-box nature limits interpretability, posing a major obstacle to clinical translation. NEW METHOD: Latent representation learning via generative models can provide informative representations and support deeper analysis and cognitive biomarker prediction. While standard generative adversarial networks and diffusion models primarily focus on generating images from random noise, variational autoencoders offer compact, probabilistic latent representations that are well suited for downstream tasks. In this study, we propose InfoVAE-Med3D, an adaptation of the InfoVAE framework for three-dimensional brain MRI to learn informative latent representations. By explicitly relaxing the mutual information regularization penalty between inputs and latent representations, our method aims to capture richer information from input MRI data, facilitating the analysis of brain-related characteristics and downstream prediction. RESULTS: We evaluate InfoVAE-Med3D on two datasets: a healthy control dataset ([Formula: see text]) containing chronological age and sex information, and a Multiple Sclerosis (MS) dataset ([Formula: see text]) collected from the Multiple Sclerosis Center of the First Medical Faculty, Charles University, Prague, containing chronological age, sex, and Symbol Digit Modalities Test (SDMT) scores. The learned latent representations capture information related to sex and brain volumetric features, including grey and white matter volumes, as reflected in sex-related clustering and smooth transitions in brain volume measures in two-dimensional visualizations. Through comprehensive evaluations, we demonstrate that InfoVAE-Med3D learns more informative latent representations, especially when the mutual information regularization penalty is completely removed. In this setting, the model generally outperforms other variational autoencoder variants in both MRI reconstruction and prediction of brain age and SDMT scores using support vector regression, while remaining competitive with deep learning-based predictive models, particularly on the MS dataset. CONCLUSION: InfoVAE-Med3D provides informative latent representations from brain MRI data of both healthy controls and patients with MS. By improving predictive performance and providing interpretable insights into the learned latent representations, the proposed framework offers a promising approach for advancing biomarker discovery and the analysis of cognitive impairment in neurological diseases, particularly MS.
Journal IF-equivalent: 3.1 (OpenAlex 2-year mean citedness, value as of 2026-11-12, retrieved 2026-11-14; not the official Clarivate IF)Reference: Ngoc Huynh T, Duc Kien N, Thai Ninh D, Hai Anh N, Hiep Dinh T, Vaneckova M, et al. Latent Representation Learning from 3D Brain MRI for Latent Analysis and Prediction in Multiple Sclerosis. Neuroinformatics. 2026 Nov 12;24(4):73. doi:10.1007/s12021-026-09827-9. PMID: 43018840.Checked: Abstract only
See all 1 Multiple sclerosis papers →
NMOSD and MOGAD: treatment, trials and AI
No new qualifying paper for this issue.
Myasthenia gravis: treatment, trials and AI
No new qualifying paper for this issue.
Autoimmune encephalitis, CIDP and Guillain-Barre syndrome: treatment, trials and AI
No new qualifying paper for this issue.